Literature DB >> 19033587

Disparities in liver transplantation before and after introduction of the MELD score.

Cynthia A Moylan1, Carla W Brady, Jeffrey L Johnson, Alastair D Smith, Janet E Tuttle-Newhall, Andrew J Muir.   

Abstract

CONTEXT: In February 2002, the allocation system for liver transplantation became based on the Model for End-Stage Liver Disease (MELD) score. Before MELD, black patients were more likely to die or become too sick to undergo liver transplantation compared with white patients. Little information exists regarding sex and access to liver transplantation.
OBJECTIVE: To determine the association between race, sex, and liver transplantation following introduction of the MELD system. DESIGN, SETTING, AND PATIENTS: A retrospective cohort of black and white patients (> or = 18 years) registered on the United Network for Organ Sharing liver transplantation waiting list between January 1, 1996, and December 31, 2000 (pre-MELD cohort, n = 21 895) and between February 28, 2002, and March 31, 2006 (post-MELD cohort, n = 23 793). MAIN OUTCOME MEASURES: Association between race, sex, and receipt of a liver transplant. Separate multivariable analyses evaluated cohorts within each period to identify predictors of time to death and the odds of dying or receiving liver transplantation within 3 years of listing. Patients with hepatocellular carcinoma were analyzed separately.
RESULTS: Black patients were younger (mean [SD], 49.2 [10.7] vs 52.4 [9.2] years; P < .001) and sicker (MELD score at listing: median [interquartile range], 16 [12-22] vs 14 [11-19]; P < .001) than white patients on the waiting list for both periods. In the pre-MELD cohort, black patients were more likely to die or become too sick for liver transplantation than white patients (27.0% vs 21.7%) within 3 years of registering on the waiting list (odds ratio [OR], 1.51; 95% confidence interval (CI), 1.15-1.98; P = .003). In the post-MELD cohort, black race was no longer associated with increased likelihood of death or becoming too sick for liver transplantation (26.5% vs 22.0%, respectively; OR, 0.96; 95% CI, 0.74-1.26; P = .76). Black patients were also less likely to receive a liver transplant than white patients within 3 years of registering on the waiting list pre-MELD (61.6% vs 66.9%; OR, 0.75; 95% CI, 0.59-0.97; P = .03), whereas post-MELD, race was no longer significantly associated with receipt of a liver transplant (47.5% vs 45.5%, respectively; OR, 1.04; 95% CI, 0.84-1.28; P = .75). Women were more likely than men to die or become too sick for liver transplantation post-MELD (23.7% vs 21.4%; OR, 1.30; 95% CI, 1.08-1.47; P = .003) vs pre-MELD (22.4% vs 21.9%; OR, 1.08; 95% CI, 0.91-1.26; P = .37). Similarly, women were less likely than men to receive a liver transplant within 3 years both pre-MELD (64.8% vs 67.6%; OR, 0.80; 95% CI, 0.70-0.92; P = .002) and post-MELD (39.9% vs 48.7%; OR, 0.70; 95% CI, 0.62-0.79; P < .001).
CONCLUSION: Following introduction of the MELD score to the liver transplantation allocation system, race was no longer associated with receipt of a liver transplant or death on the waiting list, but disparities based on sex remain.

Entities:  

Mesh:

Year:  2008        PMID: 19033587      PMCID: PMC3640479          DOI: 10.1001/jama.2008.720

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  20 in total

1.  The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.

Authors:  Randolph L Schaffer; Sanjay Kulkarni; Ann Harper; J Michael Millis; David C Cronin
Journal:  Liver Transpl       Date:  2003-11       Impact factor: 5.799

2.  The NIDDK liver transplantation database.

Authors:  Y L Wei; K M Detre; J E Everhart
Journal:  Liver Transpl Surg       Date:  1997-01

3.  Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias.

Authors:  E Cholongitas; L Marelli; A Kerry; D W Goodier; D Nair; M Thomas; D Patch; A K Burroughs
Journal:  Am J Transplant       Date:  2007-01-11       Impact factor: 8.086

4.  Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center.

Authors:  Venodhar R Julapalli; Jennifer R Kramer; Hashem B El-Serag
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

Review 5.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.

Authors:  F Kanwal; G S Dulai; B M R Spiegel; H F Yee; I M Gralnek
Journal:  Aliment Pharmacol Ther       Date:  2005-01-15       Impact factor: 8.171

7.  Rising incidence of hepatocellular carcinoma in the United States.

Authors:  H B El-Serag; A C Mason
Journal:  N Engl J Med       Date:  1999-03-11       Impact factor: 91.245

8.  MELD [corrected] score in patients accepted for liver transplantation 1994 to 2004.

Authors:  A Flodén; M Castedal; S Friman; M Olausson; L Backman
Journal:  Transplant Proc       Date:  2006-10       Impact factor: 1.066

9.  Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation?

Authors:  D E Eckhoff; B M McGuire; C J Young; M T Sellers; L R Frenette; S L Hudson; J L Contreras; S Bynon
Journal:  Liver Transpl Surg       Date:  1998-11

10.  Results of the first year of the new liver allocation plan.

Authors:  Richard B Freeman; Russell H Wiesner; Erick Edwards; Ann Harper; Robert Merion; Robert Wolfe
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

View more
  110 in total

1.  Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease.

Authors:  Hashem El-Serag; Katherine A McGlynn; Garth N Graham; Samuel So; Charles D Howell; Ted Fang; Janelle Tangonan Anderson; Thelma King Thiel
Journal:  J Fam Pract       Date:  2010-04       Impact factor: 0.493

2.  Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.

Authors:  David Goldberg; Benjamin French; Arwin Thomasson; K Rajender Reddy; Scott D Halpern
Journal:  Liver Transpl       Date:  2011-11       Impact factor: 5.799

3.  Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital.

Authors:  Amit G Singal; Vincent Chan; Yonas Getachew; Richard Guerrero; Joan S Reisch; Jennifer A Cuthbert
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

4.  Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation.

Authors:  Şencan Acar; Murat Akyıldız; Ahmet Gürakar; Yaman Tokat; Murat Dayangaç
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

Review 5.  Kidney Failure and Liver Allocation: Current Practices and Potential Improvements.

Authors:  Varun Saxena; Jennifer C Lai
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

Review 6.  GFR Estimating Equations and Liver Disease.

Authors:  Tomasz Beben; Dena E Rifkin
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

7.  Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.

Authors:  David Goldberg; Benjamin French; Peter Abt; Sandy Feng; Andrew M Cameron
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

8.  Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients.

Authors:  Robert J Wong; James Wantuck; Antonia Valenzuela; Aijaz Ahmed; Clark Bonham; Amy Gallo; Marc L Melcher; Glen Lutchman; Waldo Concepcion; Carlos Esquivel; Gabriel Garcia; Tami Daugherty; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

9.  Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Authors:  Ayse L Mindikoglu; Antone R Opekun; William E Mitch; Laurence S Magder; Robert H Christenson; Thomas C Dowling; Matthew R Weir; Stephen L Seliger; Charles D Howell; Jean-Pierre Raufman; Abbas Rana; John A Goss; Saira A Khaderi; John M Vierling
Journal:  Dig Dis Sci       Date:  2018-02-01       Impact factor: 3.199

10.  Disparities in lung transplantation before and after introduction of the lung allocation score.

Authors:  Keith M Wille; Kathy F Harrington; Joao A deAndrade; Sonia Vishin; Robert A Oster; Richard A Kaslow
Journal:  J Heart Lung Transplant       Date:  2013-04-09       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.